These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 6311749)

  • 21. Differential response of the bvg virulence regulon of Bordetella pertussis to MgSO4 modulation.
    Scarlato V; Rappuoli R
    J Bacteriol; 1991 Nov; 173(22):7401-4. PubMed ID: 1938931
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High frequency of independent IS50 transposition during Tn5 mutagenesis of Bordetella pertussis virulence-associated genes.
    Ward MJ; Duggleby CJ; Parton R; Coote JG
    Lett Appl Microbiol; 1992 Oct; 15(4):137-41. PubMed ID: 1368786
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bordetella pertussis induces apoptosis in macrophages: role of adenylate cyclase-hemolysin.
    Khelef N; Zychlinsky A; Guiso N
    Infect Immun; 1993 Oct; 61(10):4064-71. PubMed ID: 8406793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adenylate cyclase toxin is critical for colonization and pertussis toxin is critical for lethal infection by Bordetella pertussis in infant mice.
    Goodwin MS; Weiss AA
    Infect Immun; 1990 Oct; 58(10):3445-7. PubMed ID: 2401570
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of subunits of pertussis toxin in Tn5-induced Bordetella mutants deficient in toxin biological activity.
    Marchitto KS; Munoz JJ; Keith JM
    Infect Immun; 1987 May; 55(5):1309-13. PubMed ID: 2883124
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deletions affecting hemolytic and toxin activities of Bordetella pertussis adenylate cyclase.
    Bellalou J; Sakamoto H; Ladant D; Geoffroy C; Ullmann A
    Infect Immun; 1990 Oct; 58(10):3242-7. PubMed ID: 2401563
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bordetella pertussis adenylate cyclase: a toxin with multiple talents.
    Goyard S; Sebo P; D'Andria O; Ladant D; Ullmann A
    Zentralbl Bakteriol; 1993 Apr; 278(2-3):326-33. PubMed ID: 8347936
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bordetella pertussis adenylate cyclase toxin and hemolytic activities require a second gene, cyaC, for activation.
    Barry EM; Weiss AA; Ehrmann IE; Gray MC; Hewlett EL; Goodwin MS
    J Bacteriol; 1991 Jan; 173(2):720-6. PubMed ID: 1987161
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum resistance in bvg-regulated mutants of Bordetella pertussis.
    Fernandez RC; Weiss AA
    FEMS Microbiol Lett; 1998 Jun; 163(1):57-63. PubMed ID: 9631546
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of adhesins and toxins in invasion of human tracheal epithelial cells by Bordetella pertussis.
    Bassinet L; Gueirard P; Maitre B; Housset B; Gounon P; Guiso N
    Infect Immun; 2000 Apr; 68(4):1934-41. PubMed ID: 10722585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A 23-kilodalton protein, distinct from BvgA, expressed by virulent Bordetella pertussis binds to the promoter region of vir-regulated toxin genes.
    Huh YJ; Weiss AA
    Infect Immun; 1991 Jul; 59(7):2389-95. PubMed ID: 2050404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies on phase variation in Bordetella pertussis.
    Goldman S; Hanski E; Fish F
    Dev Biol Stand; 1985; 61():255-64. PubMed ID: 2872111
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of vir-activated TnphoA gene fusions in Bordetella pertussis.
    Finn TM; Shahin R; Mekalanos JJ
    Infect Immun; 1991 Sep; 59(9):3273-9. PubMed ID: 1652562
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Murine model for pertussis vaccine encephalopathy: role of the major histocompatibility complex; antibody to albumin and to Bordetella pertussis and pertussis toxin.
    Steinman L; Weiss A; Adelman N; Lim M; Oehlert J; Zuniga R; Hewlett E; Falkow S
    Dev Biol Stand; 1985; 61():439-46. PubMed ID: 2872126
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Virulence factors of Bordetella pertussis.
    Mooi FR
    Antonie Van Leeuwenhoek; 1988; 54(5):465-74. PubMed ID: 2904800
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional analysis of the cya promoter of Bordetella pertussis.
    Goyard S; Ullmann A
    Mol Microbiol; 1993 Mar; 7(5):693-704. PubMed ID: 8469114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of biological activities of Bordetella pertussis mutants lacking the ability to produce filamentous hemagglutinin with similar activities of other smooth strains.
    Watanabe M; Munoz JJ
    Microbiol Immunol; 1982; 26(10):965-9. PubMed ID: 6298581
    [No Abstract]   [Full Text] [Related]  

  • 38. Bordetella pertussis and Bordetella parapertussis: two immunologically distinct species.
    Khelef N; Danve B; Quentin-Millet MJ; Guiso N
    Infect Immun; 1993 Feb; 61(2):486-90. PubMed ID: 8423077
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A new assay for invasion of HeLa 229 cells by Bordetella pertussis: effects of inhibitors, phenotypic modulation, and genetic alterations.
    Lee CK; Roberts AL; Finn TM; Knapp S; Mekalanos JJ
    Infect Immun; 1990 Aug; 58(8):2516-22. PubMed ID: 2370104
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The C-terminal domain is essential for protective activity of the Bordetella pertussis adenylate cyclase-hemolysin.
    Betsou F; Sebo P; Guiso N
    Infect Immun; 1995 Sep; 63(9):3309-15. PubMed ID: 7642260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.